ESC 365 - The prognostic impact of cardiac Metaiodobenzylguanidine imaging related to left ventricular geometry in patients with acute decompensated heart failure: a prospective study

ESC Professional Premium Access

The prognostic impact of cardiac Metaiodobenzylguanidine imaging related to left ventricular geometry in patients with acute decompensated heart failure: a prospective study

Session: Acute heart failure: imaging and haemodynamic

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor K. Kayama (Nagoya, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Kiyomi Kayama

Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan)

0 follower

8 more presentations in this session

Is a change of the current echocardiographic red flag for left ventricular wall thickness useful in cardiac amyloidosis screening?

Speaker: Professor G. Polzl (Innsbruck, AT)

Hemodynamic profile of obesity in cardiogenic shock

Speaker: Doctor M. Guglin (Indianapolis, US)

Hemodynamic forces analysis using transthoracic echocardiogram in acute heart failure

Speaker: Doctor V. Vassia (Turin, IT)

Exosomal preconditioning of human iPSC-derived cardiomyocytes beneficially alter cardiac electrophysiology during hypoxia.

Speaker: Mr O. Rosand (Trondheim, NO)

The prognostic impact of follow-up cardiac Metaiodobenzylguanidine imaging: relation to differential trajectories in left ventricular ejection fraction after acute decompensation

Speaker: Doctor K. Kayama (Nagoya, JP)

Access the full session

Acute heart failure: imaging and haemodynamic

Speakers: Doctor K. Kayama, Professor G. Polzl, Doctor M. Guglin, Doctor V. Vassia, Mr O. Rosand...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources